1. Home
  2. PRAX vs FG Comparison

PRAX vs FG Comparison

Compare PRAX & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • FG
  • Stock Information
  • Founded
  • PRAX 2015
  • FG 1959
  • Country
  • PRAX United States
  • FG United States
  • Employees
  • PRAX N/A
  • FG N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • FG Life Insurance
  • Sector
  • PRAX Health Care
  • FG Finance
  • Exchange
  • PRAX Nasdaq
  • FG Nasdaq
  • Market Cap
  • PRAX 4.0B
  • FG 4.2B
  • IPO Year
  • PRAX 2020
  • FG N/A
  • Fundamental
  • Price
  • PRAX $178.75
  • FG $29.44
  • Analyst Decision
  • PRAX Strong Buy
  • FG Hold
  • Analyst Count
  • PRAX 13
  • FG 2
  • Target Price
  • PRAX $202.85
  • FG $41.00
  • AVG Volume (30 Days)
  • PRAX 1.4M
  • FG 166.0K
  • Earning Date
  • PRAX 11-07-2025
  • FG 11-06-2025
  • Dividend Yield
  • PRAX N/A
  • FG 2.98%
  • EPS Growth
  • PRAX N/A
  • FG N/A
  • EPS
  • PRAX N/A
  • FG 2.52
  • Revenue
  • PRAX $7,765,000.00
  • FG $5,309,000,000.00
  • Revenue This Year
  • PRAX N/A
  • FG N/A
  • Revenue Next Year
  • PRAX $20.00
  • FG $19.65
  • P/E Ratio
  • PRAX N/A
  • FG $11.69
  • Revenue Growth
  • PRAX 338.45
  • FG 1.86
  • 52 Week Low
  • PRAX $26.70
  • FG $28.70
  • 52 Week High
  • PRAX $205.89
  • FG $50.75
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 80.27
  • FG 37.16
  • Support Level
  • PRAX $164.75
  • FG $29.21
  • Resistance Level
  • PRAX $192.96
  • FG $29.68
  • Average True Range (ATR)
  • PRAX 11.99
  • FG 0.71
  • MACD
  • PRAX 13.57
  • FG 0.08
  • Stochastic Oscillator
  • PRAX 82.53
  • FG 23.80

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About FG F&G Annuities & Life Inc.

F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.

Share on Social Networks: